Annual D&A
$4.83 M
-$824.00 K-14.58%
31 December 2023
Summary:
Atara Biotherapeutics annual depreciation & amortization is currently $4.83 million, with the most recent change of -$824.00 thousand (-14.58%) on 31 December 2023. During the last 3 years, it has fallen by -$3.50 million (-42.04%). ATRA annual D&A is now -48.33% below its all-time high of $9.35 million, reached on 31 December 2021.ATRA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.23 M
-$100.00 K-7.52%
30 September 2024
Summary:
Atara Biotherapeutics quarterly depreciation & amortization is currently $1.23 million, with the most recent change of -$100.00 thousand (-7.52%) on 30 September 2024. Over the past year, it has increased by +$21.00 thousand (+1.74%). ATRA quarterly D&A is now -50.56% below its all-time high of $2.49 million, reached on 31 December 2021.ATRA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$5.16 M
+$21.00 K+0.41%
30 September 2024
Summary:
Atara Biotherapeutics TTM depreciation & amortization is currently $5.16 million, with the most recent change of +$21.00 thousand (+0.41%) on 30 September 2024. Over the past year, it has increased by +$277.00 thousand (+5.68%). ATRA TTM D&A is now -44.83% below its all-time high of $9.35 million, reached on 31 December 2021.ATRA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -14.6% | +1.7% | +5.7% |
3 y3 years | -42.0% | -46.9% | -42.8% |
5 y5 years | +29.4% | -31.3% | -22.5% |
ATRA Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -48.3% | at low | -50.6% | +2.4% | -44.8% | +6.8% |
5 y | 5 years | -48.3% | +29.4% | -50.6% | +2.4% | -44.8% | +6.8% |
alltime | all time | -48.3% | >+9999.0% | -50.6% | >+9999.0% | -44.8% | >+9999.0% |
Atara Biotherapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.23 M(-7.5%) | $5.16 M(+0.4%) |
June 2024 | - | $1.33 M(-4.4%) | $5.13 M(+2.6%) |
Mar 2024 | - | $1.39 M(+15.4%) | $5.01 M(+3.7%) |
Dec 2023 | $4.83 M(-14.6%) | $1.21 M(-0.3%) | $4.83 M(-1.0%) |
Sept 2023 | - | $1.21 M(+0.7%) | $4.88 M(-3.2%) |
June 2023 | - | $1.20 M(-1.1%) | $5.04 M(-4.5%) |
Mar 2023 | - | $1.21 M(-3.3%) | $5.28 M(-6.7%) |
Dec 2022 | $5.65 M(-39.5%) | $1.25 M(-8.3%) | $5.65 M(-17.9%) |
Sept 2022 | - | $1.37 M(-4.8%) | $6.89 M(-12.1%) |
June 2022 | - | $1.44 M(-9.6%) | $7.83 M(-10.1%) |
Mar 2022 | - | $1.59 M(-36.1%) | $8.71 M(-6.8%) |
Dec 2021 | $9.35 M(+12.2%) | $2.49 M(+7.4%) | $9.35 M(+3.7%) |
Sept 2021 | - | $2.32 M(-0.0%) | $9.01 M(+1.6%) |
June 2021 | - | $2.32 M(+4.3%) | $8.87 M(+3.1%) |
Mar 2021 | - | $2.22 M(+3.0%) | $8.61 M(+3.3%) |
Dec 2020 | $8.33 M(+17.9%) | $2.16 M(-0.7%) | $8.33 M(+3.2%) |
Sept 2020 | - | $2.17 M(+5.8%) | $8.07 M(+5.0%) |
June 2020 | - | $2.05 M(+5.3%) | $7.69 M(+4.3%) |
Mar 2020 | - | $1.95 M(+2.8%) | $7.37 M(+4.3%) |
Dec 2019 | $7.07 M(+89.4%) | $1.90 M(+6.0%) | $7.07 M(+6.3%) |
Sept 2019 | - | $1.79 M(+3.0%) | $6.65 M(+9.9%) |
June 2019 | - | $1.74 M(+5.4%) | $6.05 M(+19.9%) |
Mar 2019 | - | $1.65 M(+11.5%) | $5.05 M(+35.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | $3.73 M(+290.4%) | $1.48 M(+24.2%) | $3.73 M(+47.4%) |
Sept 2018 | - | $1.19 M(+62.8%) | $2.53 M(+59.0%) |
June 2018 | - | $731.00 K(+119.5%) | $1.59 M(+47.0%) |
Mar 2018 | - | $333.00 K(+19.8%) | $1.08 M(+13.3%) |
Dec 2017 | $956.00 K(+149.6%) | $278.00 K(+11.2%) | $956.00 K(+12.3%) |
Sept 2017 | - | $250.00 K(+12.6%) | $851.00 K(+16.3%) |
June 2017 | - | $222.00 K(+7.8%) | $732.00 K(+27.5%) |
Mar 2017 | - | $206.00 K(+19.1%) | $574.00 K(+49.9%) |
Dec 2016 | $383.00 K(+697.9%) | $173.00 K(+32.1%) | $383.00 K(+61.6%) |
Sept 2016 | - | $131.00 K(+104.7%) | $237.00 K(+104.3%) |
June 2016 | - | $64.00 K(+326.7%) | $116.00 K(+103.5%) |
Mar 2016 | - | $15.00 K(-44.4%) | $57.00 K(+18.8%) |
Dec 2015 | $48.00 K(+700.0%) | $27.00 K(+170.0%) | $48.00 K(+108.7%) |
Sept 2015 | - | $10.00 K(+100.0%) | $23.00 K(+53.3%) |
June 2015 | - | $5000.00(-16.7%) | $15.00 K(+36.4%) |
Mar 2015 | - | $6000.00(+200.0%) | $11.00 K(+83.3%) |
Dec 2014 | $6000.00(+50.0%) | $2000.00(0.0%) | $6000.00(+20.0%) |
Sept 2014 | - | $2000.00(+100.0%) | $5000.00(+25.0%) |
June 2014 | - | $1000.00(0.0%) | $4000.00(0.0%) |
Mar 2014 | - | $1000.00(0.0%) | $4000.00(0.0%) |
Dec 2013 | $4000.00 | $1000.00(0.0%) | $4000.00(+33.3%) |
Sept 2013 | - | $1000.00(0.0%) | $3000.00(+50.0%) |
June 2013 | - | $1000.00(0.0%) | $2000.00(+100.0%) |
Mar 2013 | - | $1000.00 | $1000.00 |
FAQ
- What is Atara Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual D&A year-on-year change?
- What is Atara Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly D&A year-on-year change?
- What is Atara Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM D&A year-on-year change?
What is Atara Biotherapeutics annual depreciation & amortization?
The current annual D&A of ATRA is $4.83 M
What is the all time high annual D&A for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual depreciation & amortization is $9.35 M
What is Atara Biotherapeutics annual D&A year-on-year change?
Over the past year, ATRA annual depreciation & amortization has changed by -$824.00 K (-14.58%)
What is Atara Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of ATRA is $1.23 M
What is the all time high quarterly D&A for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly depreciation & amortization is $2.49 M
What is Atara Biotherapeutics quarterly D&A year-on-year change?
Over the past year, ATRA quarterly depreciation & amortization has changed by +$21.00 K (+1.74%)
What is Atara Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of ATRA is $5.16 M
What is the all time high TTM D&A for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM depreciation & amortization is $9.35 M
What is Atara Biotherapeutics TTM D&A year-on-year change?
Over the past year, ATRA TTM depreciation & amortization has changed by +$277.00 K (+5.68%)